Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 307 clinical trials
None
Gonadal Dysfunction in Male Long-term Survivors of Malignant Lymphoma; Vitality

Lymphoma (DLBCL). The study aims to assess whether low levels of testosterone in the blood of patients cured for aggressive lymphoma, can be effectively treated with Testosterone gel, and if treatment with

androgel
testosterone level
testosterone
sexual dysfunction
cancer
  • 10 views
  • 19 Jun, 2021
  • 3 locations
None
To Determine an Effective Dose of VERU-100 for the Treatment of Advanced Prostate Cancer

To determine an effective dose of VERU-100 for the treatment of advanced prostate cancer by assessing its effect on testosterone levels by Day 28 and maintenance through Day 91.

  • 0 views
  • 04 Nov, 2021
  • 19 locations
None
Effect of Gender Affirming Hormone Therapy on Glucose Metabolism

The study will test: whether estrogen treatment in transwomen is associated with improved insulin sensitivity and beta cell function whether testosterone treatment in

  • 0 views
  • 15 Feb, 2021
  • 1 location
None
Efficacy and Safety Study of the Therapeutic Vaccine PEP223 in Prostate Cancer Patients

The purpose of this trial is to investigate whether treatment with this new drug will result in lower testosterone levels in men with prostate cancer. At the same time it will be

adenocarcinoma
prostate specific antigen
hormone therapy
endocrine therapy
vaccine therapy
  • 11 views
  • 07 Nov, 2020
  • 1 location
None
Transgender Estradiol Affirming Therapy

The purpose of this open label, pilot, randomized clinical trial is to evaluate the effectiveness, safety and tolerability of estrogen use in transgender female and the degree of testosterone

  • 0 views
  • 27 Aug, 2021
  • 1 location
None
Long Acting LHRH Versus Short Acting LHRH in the Treatment of Prostate Cancer

agonist is made either as short-acting (1-month) or long-acting (3 month) injections. The LHRH agonist lowers testosterone levels, which helps make delivery of TPIP easier, and more effective

adenocarcinoma
gonadorelin
brachytherapy
luteinizing hormone
hormone therapy
  • 44 views
  • 07 Nov, 2020
  • 1 location
None
The Wolverhampton Assessment Tool a Tool for Patient-reported Wellbeing in the Context of Prostate Cancer

WATapp correspond to, for example, changes in the patient's PSA, testosterone or other blood results which are routinely measured; and to find out how patients and clinicians feel about using WATapp

  • 0 views
  • 10 Oct, 2021
  • 1 location
None
Effect of Interval Aerobic Training on Hormonal Metabolic and Tumor Markers in Postmenopausal

and survival4. Moreover, high level of insulin resistance and adipose tissue increase the hormonal level of estradiol and testosterone coupled with lower SHBG level. It was noticed that being

  • 0 views
  • 30 Sep, 2021
  • 1 location
None
  • 30 views
  • 14 Nov, 2021
  • 1 location
None
Influence of Sex Hormones Variation During Third Trimester of Pregnancy and Post-partum on QT Interval Duration

QT interval prolongation, corrected for heart rate (QTc), either spontaneous or drug-induced, is associated with an increased risk of torsades de pointes and sudden death. Women are at higher risk of torsades de pointes, particularly during post-partum and the follicular phase. The aim of this study is to explore if …

  • 0 views
  • 28 Jan, 2021
  • 1 location